← Archive

The ABA Warning No One in Pediatric Therapy PE Is Pricing In

Private equity is rolling up pediatric speech, OT, and PT practices using the same playbook that drove ABA consolidation from 2018–2022. North Carolina's proposed Clinical Coverage Policy 8F is the first visible state-level regulatory backlash — and a template for what happens when therapy Medicaid spend concentrates fast enough to attract legislative attention. The SLP/OT/PT roll-up thesis doesn't break on the acquisition logic. It breaks on the assumption that the policy environment will hold as the category scales.

The Playbook That Built a Category

The story of PE in pediatric therapy starts with ABA, because ABA already has an ending.

From 2018 to 2022, private equity deployed the same acquisition logic across applied behavior analysis for autism that it had used in urgent care, dental, and dermatology: identify a fragmented, clinician-constrained specialty with durable reimbursement, acquire independent practices at below-market multiples, centralize back-office and recruiting infrastructure, and build regional density until the platform commands payer leverage. By 2024, a JAMA Pediatrics research letter documented 574 PE-owned autism service sites across 42 states, the result of 142 separate deals concentrated in states with higher autism prevalence and stronger insurance mandates. The leading sponsors, including NexPhase Capital (Action Behavior Centers, Behavior Frontiers), built platforms that operated in 12 or more states and served tens of thousands of children.

The same logic is now running in speech-language pathology, occupational therapy, and physical therapy. Sidekick Therapy Partners, backed by Great Hill Partners, acquired Speechcenter in July 2024 and Word of Mouth Clinical Associates in April 2026, deepening its footprint across Tennessee and North Carolina. Ivy Rehab, backed by Waud Capital since 2016, grew to more than 450 clinics including roughly 100 pediatric-dedicated sites, in part by acquiring smaller pediatric therapy groups such as Coastline Therapy Group's four North Carolina locations. These platforms are not inventing a new acquisition model. They are applying a proven one to a category that is one market cycle behind ABA.

The structural conditions that make SLP/OT/PT attractive to PE buyers are, if anything, stronger than the conditions that drove the ABA wave. ASHA's 2024 Schools Survey found that 79% of school-based speech-language pathologists said job openings exceeded job seekers in their area, with 42% citing personnel shortage, nearly double 2016 levels. BLS projects 18% employment growth for SLPs from 2023 to 2033 and 14% growth for OTs from 2024 to 2034. A persistent structural shortage means that any acquirer who can centralize recruiting, provide competitive benefits, and reduce administrative burden has a genuine value proposition to independent practice owners who are otherwise one therapist departure away from a staffing crisis. Sidekick is explicit about this: its school-partnership pitch centers on filling service gaps, reducing burnout, and preventing missed service minutes for districts. That is not a marketing line. It is the core acquisition thesis.

The reimbursement picture adds further pressure on independent operators. Medicaid routinely pays well below Medicare benchmarks for therapy services, often in the 55% to 75% range for physician-fee proxies. Policy volatility compounds the problem: North Carolina reversed Medicaid rate reductions in late 2025 that had cut providers 3% to 10%; Washington pulled back proposed cuts to speech, OT, and PT in March 2026 after provider advocacy; Idaho's April 2026 final budget removed proposed Medicaid coverage cuts but preserved a 4% provider rate reduction. Independent practices absorb that volatility directly. Scaled platforms can hedge it. That asymmetry is why practice owners are selling.

What ABA Tells Us About the Ending

Here is what the ABA arc shows once you run it to completion: concentrated Medicaid spend is a policy magnet.

North Carolina's ABA Medicaid spending rose from $1.9 million in 2020 to more than $505 million in 2025. The state projects that figure will exceed $1 billion by 2027 if nothing changes. Beneficiaries receiving ABA rose from 8,704 in 2024 to 13,447 in 2025, with average Medicaid spend reaching nearly $37,600 per patient. North Carolina Health News found that payments were concentrated among a small number of providers: ABS Kids received $64.91 million, Hopebridge received $14.63 million, and Kind Behavioral Health received $13.4 million or more. A Private Equity Stakeholder Project report found 15 PE-backed ABA providers operating 130 or more facilities in the state.

The proposed regulatory response is worth reading at the code level because it is targeted precisely at the operational model that generated the cost concentration. NC DHHS's draft Clinical Coverage Policy 8F revisions would prohibit telehealth delivery for the three most frequently billed ABA codes (97152, 97153, 97154), cap telehealth for protocol modification at 10% of sessions absent written justification, require supervisors to reside in North Carolina, bar most out-of-state providers beyond a 40-mile border exception, require a minimum of six parent training sessions per six-month authorization period, and mandate BACB or QABA certification for behavior technicians within 120 days of employment. Phase 1 implementation targets August 1, 2026.

Every one of those provisions adds cost to a multi-state platform and comparatively little cost to a local practice. The in-state supervision requirement eliminates the cost arbitrage of supervising North Carolina sessions from lower-cost markets. The out-of-state provider restriction reduces the addressable revenue base for national platforms with small NC footprints. The technician certification mandate accelerates a credentialing timeline that small practices can often accommodate in-house but that large platforms must operationalize at scale. Telehealth restrictions remove the margin structure that makes virtual ABA delivery economically viable and clip the most cost-effective delivery channel for rural access.

This is not punitive. It is structural. When a state's Medicaid ABA spend rises by 347% in three years, the program office's job is to slow it. The tools available are utilization controls, provider accountability standards, and delivery restrictions. Those tools, applied precisely, land hardest on the operational model that generated the cost growth in the first place.

The federal signal reinforces the state one. HHS-OIG reported in early 2026 that Colorado's fee-for-service Medicaid ABA spend rose from $60.1 million in 2019 to $163.5 million in 2023, with at least $77.8 million identified as improper payments. Maine's analogous spend rose from $52.2 million to $80.6 million over the same period, with at least $45.6 million in improper payments. Indiana and Wisconsin audit precedents from 2024 and 2025 follow the same pattern. HHS-OIG is methodically auditing state ABA programs, and the audit findings are generating the justification for the utilization controls that follow. Texas, California, and Florida have not yet executed a North Carolina-style tightening, but each has 81, 97, and 36 PE-owned autism service sites respectively, per the JAMA Pediatrics/Brown data set. The conditions for a similar policy response are present in all three states.

What Pediatric Therapy Platforms Should Do With This

The SLP/OT/PT roll-up thesis does not collapse on the ABA regulatory arc. It recalibrates.

The clearer version of the investment thesis has two parts that need to be held together. Part one: the structural conditions for PE consolidation in pediatric therapy are real and durable. Workforce scarcity, reimbursement volatility, and administrative complexity are driving practice-owner exits, and scaled platforms solve real problems that independent operators cannot address alone. Sidekick's school-Medicaid flywheel, Ivy Rehab's density and brand infrastructure, and the broader logic of centralized recruiting in a supply-constrained market will generate consolidation regardless of what any particular investor decides.

Part two: that consolidation will eventually generate Medicaid cost concentration that attracts the same regulatory response ABA is now receiving. The timeline is not predetermined. SLP/OT/PT is earlier-stage than ABA was in 2020, and the absolute spend levels are lower. But the structural mechanism is the same: PE acquisition drives geographic density, density enables Medicaid billing at scale, scale generates concentrated spend, concentrated spend generates legislative attention, and legislative attention produces the provider accountability standards and delivery restrictions that were not priced into the acquisition multiples.

The practical implication for platforms already operating in the space is not to stop consolidating. It is to build for a policy environment that will eventually look more like the proposed NC ABA rules than like the current permissive status quo. That means building credentialing and supervision infrastructure that is already state-compliant before mandates arrive, developing in-person delivery capacity that does not depend on the telehealth economics that regulators will eventually restrict, and building the parent training and outcome documentation systems that accountability standards will require. Platforms that build this infrastructure now, before it is mandated, will operate more cheaply than platforms that have to retrofit it under regulatory pressure.

The digital behavioral health comparators, Brightline, Cartwheel Care, and Marble Health, are mostly not in this conversation yet. Brightline is a hybrid pediatric mental health practice concentrated in New York, New Jersey, and Connecticut. Cartwheel serves 350 school districts across 15 states with virtual therapy and psychiatry. Marble is school-embedded virtual care for mild-to-moderate behavioral health concerns. None of these platforms is currently acquiring SLP/OT/PT clinics, and none is generating the kind of Medicaid cost concentration that triggers a policy response. The one company that blurs the boundary is Cortica, which bundles ABA, speech, occupational therapy, developmental therapy, and medical care under one roof across multiple states, and which has disclosed a value-based arrangement with Point32Health in Massachusetts. Cortica is a preview of what the integrated neurodevelopment platform looks like once the SLP/OT/PT roll-up and the digital behavioral health model converge. That convergence is not here yet, but it is where the market is heading.

For investors, the calibration question is: which platforms will be best positioned when the NC ABA policy frame travels to multi-specialty pediatric therapy? The answer looks like platforms with diversified state footprints that reduce single-state Medicaid concentration, credentialing and compliance infrastructure that can absorb new accountability standards without operational disruption, a value-based contracting capability that gives payers an alternative to utilization controls, and enough clinical volume in in-person delivery to survive telehealth restrictions. The roll-ups that build for that environment are building a durable business. The ones that optimize purely for margin at current utilization assumptions are building toward the same regulatory reckoning that ABA is navigating right now.

---